Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
6 drugs in development
By Therapeutic Area
top 4
R&D Momentum
77/100
Pipeline Velocity
41/100
Trial Completion Rate
89/100
Pipeline Concentration
25/100
Pipeline Freshness
0/100
Strategic Signals
Activity
Last 14 days
Adrenal Function in Critical Illness
The Effects of Hydrocortisone, Melatonin, and Placebo on Symptoms of Jet Lag
Evaluation of Patients With Liver Disease
Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)